Compound Profile
Huperzine A
Huperzine A is best framed around acetylcholinesterase inhibition and memory support research, with conservative cognitive framing and safety screening for cholinergic sensitivity, seizure history, bradycardia, and cholinergic or anticholinergic medication conflicts.
Last reviewed: •1 human studies cited
C PreliminaryMonograph visual
Huperzine A
Generated profile category visual
Where to go next — guides & comparisons
Continue reading
- If you want sharper focus → Focus guides
- If you want to browse more compounds → All compounds
Quick Stats
Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
CNS/Autonomic Receptors, Ion Channels, CYP/P Gp
Avoid / review if
Bradycardia Or Other Cardiac Conduction Disorders (Cholinergic Slowing Of Heart Rate), Seizure Disorders Or Epilepsy Without Clinician Guidance, Asthma Or COPD (Cholinergic Bronchoconstriction Risk)
Found In
Botanicals that contain Huperzine A, with full herb profiles.
Safety & Cautions
Review before use if any apply: Bradycardia Or Other Cardiac Conduction Disorders (Cholinergic Slowing Of Heart Rate), Seizure Disorders Or Epilepsy Without Clinician Guidance, Asthma Or COPD (Cholinergic Bronchoconstriction Risk).
Evidence Summary
C PreliminaryEvidence lens
Useful signal, but study design, dose, and population still matter.
ModeratePreliminary evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Neurotransmitter Modulation · Neuroprotective Activity
Research maturity: More interpretable — main contexts: CNS/Autonomic Receptors · Ion Channels · CYP/P Gp
Safety boundary: Safety note available — Review before use if any apply: Bradycardia Or Other Cardiac Conduction Disorders (Cholinergic Slowing Of Heart Rate), Seizure Disorders Or Epilepsy Without Clinician Guidance, Asthma Or COPD (Cholinergic Bronchoconstric
This profile cites 1 human study.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Huperzine A has a preliminary evidence evidence rating.
NootropicFocus
Citation density
0.2
Sources
1
Effects
5
Research recency
Mixed recency
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
A
Strong
Multiple RCTs, consistent direction, adequate effect size
B
Moderate
Some RCTs or consistent observational data in humans
C
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
D
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (1)Cited studies informing this profile. RCTs and reviews shown first.
| Study | Type | Sample | Source |
|---|---|---|---|
Requires manual source normalization to PMID, DOI, PMC, or authoritative URL. | — | — | — |
How Huperzine A Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Huperzine A Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways▼
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Inflammatory Signaling ModulationNeurotransmitter ModulationNeuroprotective Activity
Condition guides
Continue exploring
Related research paths
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Huperzine A
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Huperzine A evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Compound profile context
How to interpret Huperzine A
Huperzine A dosage by use case, onset and duration, safety limits, and interactions for cns/autonomic receptors, graded against research. Mechanistic Evidence… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Huperzine A, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.